Is Stoke Therapeutics, Inc. (STOK) a Buy, Sell, or Hold?
NASDAQ : STOK
Stoke Therapeutics, Inc. — Competitors
$29.625 USD
$0.33 (1.11%)
- Volume
- 159.77K
- Average Volume
- 714.5K
- Market Capitalization
- $1.85B
- P/E Ratio
- -10.47
- Dividend Yield
- 0.00%
- Price Target
- $44.00
- Year High
- $40.22
- Year Low
- $12.25
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.99
STOK vs. The Competition
| Properties | STOK | ARDX | BCRX | NTLA |
|---|---|---|---|---|
| Market Cap | $1.85B | $1.27B | $2.49B | $1.22B |
| Shares Outstanding | $62.28M | $247.03M | $254.16M | $112.21M |
| P/E Ratio | -10.47 | -21.87 | -5.67 | -3.06 |
| EPS | -2.69 | -0.24 | -1.89 | -3.33 |
| Day Low | 29.23 | 5.085 | 9.6 | 10.63 |
| Day High | 30.755 | 5.21 | 9.91 | 11.31 |
| Year Low | 12.25 | 4.075 | 6 | 7.95 |
| Year High | 40.22 | 8.4 | 11.22 | 28.25 |
| Average Price 50 | 30.4075 | 5.6616 | 9.2406 | 13.91 |
| Average Price 200 | 31.66108 | 6.02995 | 8.1766 | 13.40318 |
| Volume | 159.77K | 637.5K | 1.27M | 1.13M |
| Average Volume | - | - | - | - |